{"pub": "marketwatch", "url": "https://marketwatch.com/articles/cvs-stock-verticle-integration-health-care-benefits-insurance-pharmacy-51571147790", "downloaded_at": "2019-10-15 15:07:40.533677+00:00", "title": "CVS Stock Is Rising as Its Integration Gives It a \u2018Competitive Advantage\u2019", "language": "en", "text": "CVS Health is a industry-spanning monolith\u2014a vertically integrated company that owns pharmacies, a pharmacy-benefit manager, and a health-insurance company. In a note out Tuesday morning, a J.P. Morgan analyst said that is a major strength.\n\n\u201cWe believe the company is one of the best positioned companies across our coverage universe over the longer term,\u201d wrote J.P. Morgan analyst Lisa Gill, who rates the stock Overweight, with an $88 price target. The stock closed at $62.99 on Monday. \u201cWe are positive on the company\u2019s integrated...", "description": "J.P. Morgan analyst Lisa Gill said the integrated model will boost the whole company, but that it will particularly help the health-care benefits segment.", "authors": ["Josh Nathan-Kazis"], "top_image": "https://asset.barrons.com/public/resources/images/ON-DG688_CVS101_OR_20191015085240.jpg", "published_at": "2019-10-15"}